Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
   Rule 13d-1(b)
   Rule 13d-1(c)
   Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G




Comment for Type of Reporting Person:  Based on 16,956,415 shares of Common Stock outstanding as of May 1, 2026, as reported by Q32 Bio Inc. in its Annual Report on Form 10-K filed with the SEC on May 5, 2026.


SCHEDULE 13G





SCHEDULE 13G



 
Opaleye Management Inc.
 
Signature:/s/ James Silverman
Name/Title:President
Date:07/31/2026
 
Opaleye, L.P.
 
Signature:/s/ James Silverman
Name/Title:General Partner
Date:07/31/2026
 
James Silverman
 
Signature:/s/ James Silverman
Name/Title:Individually
Date:07/31/2026
Exhibit Information

Exhibit 99.1 Joint Filing Agreement by and among the reporting persons


ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

EX-99.1